(Bloomberg) -- The following is a list of companies
whose shares may have unusual price changes in U.S. exchanges on
July 23. This preview includes news that broke after exchanges
closed. Stock symbols are in parentheses after company names.
Amgen Inc. (AMGN US): The company's anemia drugs will be
restricted at high doses for patients on kidney dialysis
treatment, according to a statement from the U.S. health program
for the elderly and disabled. The policy will provide greater
restrictions on dosages when a patient's level of hemoglobin
exceeds 13 grams per deciliter of blood, the Medicare agency
said. The stock rose 61 cents to $56.18 in regular trading.
Read more at Bloomberg Stocks News
whose shares may have unusual price changes in U.S. exchanges on
July 23. This preview includes news that broke after exchanges
closed. Stock symbols are in parentheses after company names.
Amgen Inc. (AMGN US): The company's anemia drugs will be
restricted at high doses for patients on kidney dialysis
treatment, according to a statement from the U.S. health program
for the elderly and disabled. The policy will provide greater
restrictions on dosages when a patient's level of hemoglobin
exceeds 13 grams per deciliter of blood, the Medicare agency
said. The stock rose 61 cents to $56.18 in regular trading.
Read more at Bloomberg Stocks News
No comments:
Post a Comment